Lexotan (Bromazepam)

Bromazepam acts on the central nervous system to alleviate anxiety‑related conditions.

• Anxiety disorders: reduces excessive worry, tension and physiological symptoms of anxiety.
• Short‑term relief of anxiety symptoms: provides rapid calming effect during acute stress episodes.
• Insomnia related to anxiety: improves sleep onset by diminishing anxiety‑driven arousal.

• Bromazepam binds to the benzodiazepine site on the GABA_A receptor complex, acting as a positive allosteric modulator. This enhances the inhibitory effect of the neurotransmitter GABA, increasing chloride ion influx and hyperpolarizing neuronal membranes, which leads to reduced neuronal excitability and a calming, anxiolytic effect.

Bromazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Impaired coordination: reduced motor control and balance.
• Memory impairment: difficulty recalling recent events.
• Fatigue: general lack of energy.
• Gastrointestinal discomfort: nausea or upset stomach.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing, especially with other depressants.
• Severe allergic reactions: rash, itching, swelling, or difficulty breathing.
• Dependence and withdrawal: risk of physical dependence with prolonged use, leading to withdrawal symptoms upon abrupt cessation.
• Paradoxical reactions: increased anxiety, agitation, or aggression in rare cases.
• Depression or suicidal thoughts: emergence or worsening of mood disturbances.
• Hepatic dysfunction: abnormal liver enzyme elevations.

Bromazepam requires careful consideration of patient‑specific factors and safe handling practices.

• Assess renal and hepatic function: adjust use if organ impairment is present.
• Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal.
• Use caution in elderly patients: increased sensitivity to sedation and falls.
• Avoid concomitant alcohol or CNS depressants: heightened risk of excessive sedation.
• Pregnancy and lactation: discuss risks with a healthcare professional before use.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Bromazepam can interact with other substances that affect the central nervous system or its metabolism.

Major Interactions (Avoid)

• Opioids, barbiturates, or other benzodiazepines: risk of profound sedation and respiratory depression.
• Alcohol: additive central nervous system depression leading to marked drowsiness.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase bromazepam plasma levels.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., carbamazepine, rifampicin): may reduce therapeutic effect.
• Antidepressants (e.g., SSRIs, SNRIs): can enhance sedative properties.
• Antihistamines: may increase drowsiness and impair coordination.